Research Partners

Lung Foundation Australia have established partnerships with organisations who want to collaborate, increase research funding opportunities, and who have a commitment to research into lung disease.

We are proud of our partnerships as together we are stronger.

Our Partnerships

Thoracic Society of Australia and New Zealand

Lung Foundation Australia has worked for over 20 years with the Thoracic Society of Australia & New Zealand (TSANZ) to raise funds for research, award research funding, and encourage more research funding is dedicated to investigating lung disease in Australia.

The TSANZ’s Scientific Review Committee is appointed to review or judge applications received for the Lung Foundation’s Awards and Grants program.  Specifically the respiratory focused applications.   Our oncology grants program is reviewed by a separate committee that comprises of thoracic cancer specialists.

Lung Foundation Australia and Thoracic Society of Australia & New Zealand (TSANZ) have joined forces to raise funding for research into respiratory disease. This joint program is known as Lungs for Life and is in response to critical underfunding for respiratory research in Australia.

Better Breathing Foundation  (add logo)

Lung Foundation Australia is delighted to announce our new partnership with the Better Breathing Foundation, a not-for-profit organisation which supports early career allied health research students to conduct high quality research on chronic lung diseases.

Through this new and exciting collaboration, we will be offering PhD Scholarships to support early career allied health research students complete their doctoral studies and find solutions and improve care for those living with a chronic lung disease.

The Better Breathing Foundation, which was established by Dr Zoe McKeough from the University of Sydney has already funded its first allied health PhD via its fundraising efforts.

This new Lung Foundation Australia/Better Breathing Foundation Allied Health PhD Scholarship for Lung Disease Research will form part of Lung Foundation Australia’s annual Research Awards Program. Applications for this new PhD scholarship will open mid-year 2017.

Co-Funding Partnerships

Lung Foundation Australia is grateful to the follow Universities or Research Institutes who have assisted in building our research program.  Those noted below have co-funded or matched our funding contribution to a research study and conducted the research within their organisation. Some of those listed have supported and co-funded more than one research study.

  • Edith Cowan University, WA
  • University of Tasmania, TAS
  • Federation University, VIC
  • University of Melbourne, VIC
  • University of Newcastle, NSW
  • University of Queensland, QLD
  • University of Sydney, NSW
  • Walter and Eliza Hall Institute of Medical Research, VIC

Industry Partnerships

Boehringer Ingelheim

Lung Foundation Australia and Boehringer Ingelheim have collaborated on the COPD Research Fellowship since 1995.  Since that date collaboratively we have disbursed more than $XX million to successful applications for COPD research projects.  As a research based pharmaceutical company, Boehringer Ingelheim is committed to long-term investment in the future.   We are deeply grateful for this sustained and focused partnership which has underpinned the significant progress made in Chronic Obstructive Pulmonary Disease over the years.

Click here to view some of these research outcomes and to hear from some of the researchers who have received this Fellowship.

A Menarini Australia Pty Ltd

Lung Foundation Australia and A Menarini Australia have collaborated for several years and support research that focuses on improving outcomes for people living with COPD.  A Menarini have supported research awards and Professional development funding that the Lung Foundation awards to Australian health professionals to attend key medical conferences (nationally/internationally) to develop their professional and research careers and network with peers.

Actelion Pharmaceuticals Australia Pty Ltd

Lung Foundation Australia and Actelion Pharmaceuticals Australia have recently formed a partnership to facilitate and support ongoing research and professional development in a rare lung disease Pulmonary Arterial Hypertension (PAH).

If you would like to partner with the Lung Foundation on a lung disease research project please contact the General Manager for Research on 07 3251 3600 or via